FindTrial
Sign In

The effect and mechanism of lipoxins on the pathogenesis of preeclampsia.

The effect and mechanism of lipoxins on the pathogenesis of preeclampsia.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CCC-13003940
Enrollment
Unknown
Registered
2013-12-01
Start date
2011-04-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Interventions

control group:none
Preeclampsia group:none

Sponsors

1st Affiliated Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
26 Years to 35 Years

Inclusion criteria

Inclusion criteria: preeclampsia defined by hypertension (systolic and diastolic blood pressures higher than 140/90mmHg and proteinuria 0.3 g/day), were recruited from 1st Affiliated Hospital, Wenzhou Medical College. As comparative groups, Single pregnancy,pregnant women were originally selected to have similar characteristics to those presented by preeclamptic patients, such as age, body mass index (BMI) and gestational age.

Exclusion criteria

Exclusion criteria: eliminate high blood pressure, kidney disease, diabetes, anemia, ICP and pregnancy complications (placenta previa,fetal intrauterine growth retardation,etc).

Design outcomes

Primary

MeasureTime frame
ELISA;RT-PCR;immunohistochemistr;—

Countries

China

Contacts

Public ContactZhangye Xu

1st Affiliated Hospital, Wenzhou Medical University

xuzhangye@aliyun.com+86 0577-88069204

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026